Multi-Asset Absolute Return Fund OCSE:NOVO B Holdings History
Multi-Asset Absolute Return Fund's Novo Nordisk AS Holding Summary
As of 2025-04-30, John Hancock Funds II held 94,380.00 shares of Novo Nordisk AS(OCSE:NOVO B), totaling kr6.31 Mil. This investment constitutes 2.92% of their stock portfolio, and John Hancock Funds II now holds 0% of the outstanding Novo Nordisk AS(OCSE:NOVO B) stock.
The initial trade took place in 2019Q4. And since then Multi-Asset Absolute Return Fund has made 10 purchases of OCSE:NOVO B, at an average price of kr375.96, for a total of 520,324.00 shares. In addition, there have been 11 sales at an average price of kr524.00 for 425,944.00 shares. Based on historical transaction data and OCSE:NOVO B's current price of kr433.60, Multi-Asset Absolute Return Fund's estimated gain on his OCSE:NOVO B holdings is kr68.50 Mil, reflecting a 35.01% gain to date.
Multi-Asset Absolute Return Fund OCSE:NOVO B (kr433.60) Holding Chart
Multi-Asset Absolute Return Fund OCSE:NOVO B (kr433.60) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price kr-/Share | ||
| Shares Sold | 0 | Average Price kr-/Share | ||
| Current Price kr0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
